ciprofloxacin has been researched along with Drug Refractory Epilepsy in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheraghmakani, H | 1 |
| Rezai, MS | 1 |
| Valadan, R | 1 |
| Rahimzadeh, G | 1 |
| Moradi, M | 1 |
| Jahanfekr, V | 1 |
| Moosazadeh, M | 1 |
| Tabrizi, N | 1 |
1 other study available for ciprofloxacin and Drug Refractory Epilepsy
| Article | Year |
|---|---|
Ciprofloxacin for treatment of drug-resistant epilepsy.
Topics: Adult; Anticonvulsants; Ciprofloxacin; Drug Resistant Epilepsy; Epilepsy, Generalized; Humans; Prosp | 2021 |